dc.contributor | Universidade de São Paulo (USP) | |
dc.contributor | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.contributor | Instituto Fleury | |
dc.date.accessioned | 2014-05-27T11:22:28Z | |
dc.date.accessioned | 2022-10-05T18:07:04Z | |
dc.date.available | 2014-05-27T11:22:28Z | |
dc.date.available | 2022-10-05T18:07:04Z | |
dc.date.created | 2014-05-27T11:22:28Z | |
dc.date.issued | 2007-05-21 | |
dc.identifier | Thrombosis Research, v. 120, n. 2, p. 221-229, 2007. | |
dc.identifier | 0049-3848 | |
dc.identifier | http://hdl.handle.net/11449/69670 | |
dc.identifier | 10.1016/j.thromres.2006.09.015 | |
dc.identifier | 2-s2.0-34248512217 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3919080 | |
dc.description.abstract | Introduction: Venous thrombosis (VT) and inflammation are two closely related entities. In the present investigation we assessed whether there is a relation between genetic modifiers of the inflammatory response and the risk of VT. Materials and methods: 420 consecutive and unrelated patients with an objective diagnosis of deep VT and 420 matched controls were investigated. The frequencies of the following gene polymorphisms were determined in all subjects: TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G. Results: Overall odds ratio (OR) for VT related to TNF-α- 308 G/A, LT-α+ 252 A/G, IL-6-174 G/C, A1 allele (4 bp repeat) of the IL1-ra 86 bp VNTR, IL-10-1082 A/G and CD-31 125 C/G were respectively: 1.0 (CI95: 0.8-1.5), 1.3 (CI95: 1.0-1.7), 1.1 (CI95: 0.9-1.5), 1.6 (CI95: 1-2.5), 1.2 (CI95: 0.8-1.7) and 0.8 (CI95: 0.6-1.1). A possible interaction between polymorphisms was observed only for the co-inheritance of the mutant alleles of the LT-α+ 252 A/G and IL-10-1082 G/A polymorphisms (OR = 2; CI95: 1.1-3.8). The risk of VT conferred by factor V Leiden and FII G20210A was not substantially altered by co-inheritance with any of the cytokine gene polymorphisms. Conclusions: Cytokine gene polymorphisms here investigated did not significantly influence venous thrombotic risk. © 2006 Elsevier Ltd. All rights reserved. | |
dc.language | eng | |
dc.relation | Thrombosis Research | |
dc.relation | 2.779 | |
dc.relation | 1,096 | |
dc.rights | Acesso restrito | |
dc.source | Scopus | |
dc.subject | Coagulation | |
dc.subject | Cytokines | |
dc.subject | Inflammation | |
dc.subject | Polymorphisms | |
dc.subject | Thrombosis | |
dc.subject | Venous thromboembolism | |
dc.subject | blood clotting factor 11 | |
dc.subject | blood clotting factor 5 Leiden | |
dc.subject | CD31 antigen | |
dc.subject | cytokine | |
dc.subject | interleukin 1 receptor blocking agent | |
dc.subject | interleukin 10 | |
dc.subject | interleukin 6 | |
dc.subject | lymphotoxin | |
dc.subject | tumor necrosis factor alpha | |
dc.subject | cardiovascular risk | |
dc.subject | deep vein thrombosis | |
dc.subject | genetic polymorphism | |
dc.subject | inflammation | |
dc.subject | major clinical study | |
dc.subject | medical research | |
dc.subject | Base Sequence | |
dc.subject | Case-Control Studies | |
dc.subject | DNA Primers | |
dc.subject | Interleukin 1 Receptor Antagonist Protein | |
dc.subject | Interleukin-10 | |
dc.subject | Interleukin-6 | |
dc.subject | Lymphotoxin-alpha | |
dc.subject | Middle Aged | |
dc.subject | Odds Ratio | |
dc.subject | Polymorphism, Genetic | |
dc.subject | Tumor Necrosis Factor-alpha | |
dc.subject | Variation (Genetics) | |
dc.subject | Venous Thrombosis | |
dc.title | Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY) | |
dc.type | Artigo | |